[English] 日本語
Yorodumi- PDB-3kdt: Crystal structure of peroxisome proliferator-activatedeceptor alp... -
+Open data
-Basic information
Entry | Database: PDB / ID: 3kdt | ||||||
---|---|---|---|---|---|---|---|
Title | Crystal structure of peroxisome proliferator-activatedeceptor alpha (PPARalpha) complex with N-3-((2-(4-Chlorophenyl)-5-methyl-1,3-oxazol-4-yl)methoxy)benzyl)-N-(methoxycarbonyl)glycine | ||||||
Components | Peroxisome proliferator-activated receptor alpha | ||||||
Keywords | HORMONE RECEPTOR / Nuclear Hormone Receptor / transcription regulation / Activator / DNA-binding / Lipid-binding / Receptor / Transcription | ||||||
Function / homology | Function and homology information positive regulation of transformation of host cell by virus / regulation of fatty acid transport / enamel mineralization / negative regulation of cell growth involved in cardiac muscle cell development / lipoprotein metabolic process / regulation of fatty acid metabolic process / positive regulation of fatty acid oxidation / cellular response to fructose stimulus / regulation of ketone metabolic process / behavioral response to nicotine ...positive regulation of transformation of host cell by virus / regulation of fatty acid transport / enamel mineralization / negative regulation of cell growth involved in cardiac muscle cell development / lipoprotein metabolic process / regulation of fatty acid metabolic process / positive regulation of fatty acid oxidation / cellular response to fructose stimulus / regulation of ketone metabolic process / behavioral response to nicotine / negative regulation of appetite / positive regulation of fatty acid beta-oxidation / negative regulation of hepatocyte apoptotic process / mitogen-activated protein kinase kinase kinase binding / negative regulation of leukocyte cell-cell adhesion / ubiquitin conjugating enzyme binding / negative regulation of glycolytic process / negative regulation of sequestering of triglyceride / nuclear steroid receptor activity / DNA-binding transcription activator activity / nitric oxide metabolic process / positive regulation of fatty acid metabolic process / NFAT protein binding / positive regulation of ATP biosynthetic process / negative regulation of cholesterol storage / negative regulation of macrophage derived foam cell differentiation / negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction / negative regulation of cytokine production involved in inflammatory response / epidermis development / phosphatase binding / positive regulation of lipid biosynthetic process / Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 / negative regulation of reactive oxygen species biosynthetic process / positive regulation of gluconeogenesis / negative regulation of signaling receptor activity / MDM2/MDM4 family protein binding / RORA activates gene expression / negative regulation of blood pressure / Regulation of lipid metabolism by PPARalpha / hormone-mediated signaling pathway / cellular response to starvation / response to nutrient / BMAL1:CLOCK,NPAS2 activates circadian gene expression / negative regulation of miRNA transcription / Activation of gene expression by SREBF (SREBP) / gluconeogenesis / fatty acid metabolic process / negative regulation of transforming growth factor beta receptor signaling pathway / circadian regulation of gene expression / wound healing / SUMOylation of intracellular receptors / Heme signaling / response to insulin / regulation of circadian rhythm / Transcriptional activation of mitochondrial biogenesis / PPARA activates gene expression / Cytoprotection by HMOX1 / DNA-binding transcription repressor activity, RNA polymerase II-specific / transcription coactivator binding / negative regulation of inflammatory response / Transcriptional regulation of white adipocyte differentiation / Nuclear Receptor transcription pathway / nuclear receptor activity / Circadian Clock / heart development / DNA-binding transcription activator activity, RNA polymerase II-specific / DNA-binding transcription factor binding / response to ethanol / RNA polymerase II-specific DNA-binding transcription factor binding / sequence-specific DNA binding / cell differentiation / response to hypoxia / DNA-binding transcription factor activity, RNA polymerase II-specific / DNA-binding transcription factor activity / RNA polymerase II cis-regulatory region sequence-specific DNA binding / protein domain specific binding / lipid binding / protein-containing complex binding / chromatin / positive regulation of DNA-templated transcription / negative regulation of transcription by RNA polymerase II / positive regulation of transcription by RNA polymerase II / DNA binding / zinc ion binding / nucleoplasm / nucleus Similarity search - Function | ||||||
Biological species | Homo sapiens (human) | ||||||
Method | X-RAY DIFFRACTION / SYNCHROTRON / FOURIER SYNTHESIS / Resolution: 2.7 Å | ||||||
Authors | Muckelbauer, J.K. | ||||||
Citation | Journal: J.Med.Chem. / Year: 2010 Title: Discovery of an oxybenzylglycine based peroxisome proliferator activated receptor alpha selective agonist 2-((3-((2-(4-chlorophenyl)-5-methyloxazol-4-yl)methoxy)benzyl)(methoxycarbonyl)amino) ...Title: Discovery of an oxybenzylglycine based peroxisome proliferator activated receptor alpha selective agonist 2-((3-((2-(4-chlorophenyl)-5-methyloxazol-4-yl)methoxy)benzyl)(methoxycarbonyl)amino)acetic acid (BMS-687453). Authors: Li, J. / Kennedy, L.J. / Shi, Y. / Tao, S. / Ye, X.Y. / Chen, S.Y. / Wang, Y. / Hernandez, A.S. / Wang, W. / Devasthale, P.V. / Chen, S. / Lai, Z. / Zhang, H. / Wu, S. / Smirk, R.A. / ...Authors: Li, J. / Kennedy, L.J. / Shi, Y. / Tao, S. / Ye, X.Y. / Chen, S.Y. / Wang, Y. / Hernandez, A.S. / Wang, W. / Devasthale, P.V. / Chen, S. / Lai, Z. / Zhang, H. / Wu, S. / Smirk, R.A. / Bolton, S.A. / Ryono, D.E. / Zhang, H. / Lim, N.K. / Chen, B.C. / Locke, K.T. / O'Malley, K.M. / Zhang, L. / Srivastava, R.A. / Miao, B. / Meyers, D.S. / Monshizadegan, H. / Search, D. / Grimm, D. / Zhang, R. / Harrity, T. / Kunselman, L.K. / Cap, M. / Kadiyala, P. / Hosagrahara, V. / Zhang, L. / Xu, C. / Li, Y.X. / Muckelbauer, J.K. / Chang, C. / An, Y. / Krystek, S.R. / Blanar, M.A. / Zahler, R. / Mukherjee, R. / Cheng, P.T. / Tino, J.A. #1: Journal: To be Published Title: Synthesis and Structure-Activity Relationships of 2-Aryl-4-oxazolylmethoxy Benzylglycines and 2-Aryl-4-thiazolylmethoxy Benzylglycines as Novel, Potent PPARalpha Selective Activators-PPARalpha ...Title: Synthesis and Structure-Activity Relationships of 2-Aryl-4-oxazolylmethoxy Benzylglycines and 2-Aryl-4-thiazolylmethoxy Benzylglycines as Novel, Potent PPARalpha Selective Activators-PPARalpha and PPARgamma Selective Modulation Authors: Ye, X.-Y. / Chen, S. / Zhang, H. / Locke, K.T. / O'Malley, K. / Zhang, L. / Srivastava, R. / Miao, B. / Meyers, D. / Monshizadegan, H. / Search, D. / Grimm, D. / Zhang, R. / Lippy, J. / ...Authors: Ye, X.-Y. / Chen, S. / Zhang, H. / Locke, K.T. / O'Malley, K. / Zhang, L. / Srivastava, R. / Miao, B. / Meyers, D. / Monshizadegan, H. / Search, D. / Grimm, D. / Zhang, R. / Lippy, J. / Twamley, C. / Muckelbauer, J.K. / Chang, C. / An, Y. / Hosagrahara, V. / Zhang, L. / Yang, T.-J. / Mukherjee, R. / Cheng, P.T.W. / Tino, J.A. | ||||||
History |
|
-Structure visualization
Structure viewer | Molecule: MolmilJmol/JSmol |
---|
-Downloads & links
-Download
PDBx/mmCIF format | 3kdt.cif.gz | 116.2 KB | Display | PDBx/mmCIF format |
---|---|---|---|---|
PDB format | pdb3kdt.ent.gz | 90.5 KB | Display | PDB format |
PDBx/mmJSON format | 3kdt.json.gz | Tree view | PDBx/mmJSON format | |
Others | Other downloads |
-Validation report
Summary document | 3kdt_validation.pdf.gz | 890.2 KB | Display | wwPDB validaton report |
---|---|---|---|---|
Full document | 3kdt_full_validation.pdf.gz | 873.7 KB | Display | |
Data in XML | 3kdt_validation.xml.gz | 21.2 KB | Display | |
Data in CIF | 3kdt_validation.cif.gz | 28 KB | Display | |
Arichive directory | https://data.pdbj.org/pub/pdb/validation_reports/kd/3kdt ftp://data.pdbj.org/pub/pdb/validation_reports/kd/3kdt | HTTPS FTP |
-Related structure data
-Links
-Assembly
Deposited unit |
| ||||||||
---|---|---|---|---|---|---|---|---|---|
1 |
| ||||||||
2 |
| ||||||||
3 |
| ||||||||
Unit cell |
|
-Components
#1: Protein | Mass: 31316.445 Da / Num. of mol.: 2 / Fragment: Ligand-binding domain: UNP residues 196-468 Source method: isolated from a genetically manipulated source Source: (gene. exp.) Homo sapiens (human) / Gene: PPARA, NR1C1, PPAR / Plasmid: pET28a / Production host: Escherichia coli (E. coli) / Strain (production host): BL21(DE3) / References: UniProt: Q07869 #2: Chemical | #3: Water | ChemComp-HOH / | |
---|
-Experimental details
-Experiment
Experiment | Method: X-RAY DIFFRACTION / Number of used crystals: 1 |
---|
-Sample preparation
Crystal | Density Matthews: 2.07 Å3/Da / Density % sol: 40.57 % |
---|---|
Crystal grow | Temperature: 298 K / Method: vapor diffusion Details: PEG 4000, Ammonium and magnesium acetate, VAPOR DIFFUSION, temperature 298K PH range: 6.5-7.0 |
-Data collection
Diffraction | Mean temperature: 100 K |
---|---|
Diffraction source | Source: SYNCHROTRON / Site: NSLS / Beamline: X25 / Wavelength: 1.1 Å |
Detector | Type: ADSC QUANTUM 315 / Detector: CCD / Date: Apr 28, 2004 |
Radiation | Protocol: SINGLE WAVELENGTH / Monochromatic (M) / Laue (L): M / Scattering type: x-ray |
Radiation wavelength | Wavelength: 1.1 Å / Relative weight: 1 |
Reflection | Resolution: 2.7→50 Å / Num. obs: 13931 / % possible obs: 99 % / Observed criterion σ(I): 0 / Redundancy: 3.5 % / Rmerge(I) obs: 0.079 / Rsym value: 0.079 / Net I/σ(I): 17.6 |
Reflection shell | Resolution: 2.7→2.8 Å / Redundancy: 3.6 % / Mean I/σ(I) obs: 2.8 / Rsym value: 0.429 / % possible all: 99.7 |
-Processing
Software |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Refinement | Method to determine structure: FOURIER SYNTHESIS / Resolution: 2.7→50 Å / Cor.coef. Fo:Fc: 0.914 / Cor.coef. Fo:Fc free: 0.858 / Occupancy max: 1 / Occupancy min: 1 / SU B: 19.985 / SU ML: 0.402 / Cross valid method: THROUGHOUT / σ(F): 0 / ESU R Free: 0.493 / Stereochemistry target values: MAXIMUM LIKELIHOOD / Details: HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Solvent computation | Ion probe radii: 0.8 Å / Shrinkage radii: 0.8 Å / VDW probe radii: 1.2 Å / Solvent model: MASK | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Displacement parameters | Biso max: 112.9 Å2 / Biso mean: 57.948 Å2 / Biso min: 25.85 Å2
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Refinement step | Cycle: LAST / Resolution: 2.7→50 Å
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Refine LS restraints |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
LS refinement shell | Resolution: 2.7→2.77 Å / Total num. of bins used: 20
|